Dr Mohan's current research interests takes a multi-disciplinary approach and are broadly focussed around cardiovascular medicine and psychiatry. These encompass studies to understand the pathophysiology of cardiovascular diseases in patients with psychotic disorders and in the development of treatment strategies for this group of patients. With his cardiovascular research background, Dr Mohan has developing interests in patient-oriented cardio-psychiatry based research programs aimed to improve the cardiometabolic health and medical outcomes of patients with mental illness globally, particularly in low and middle income countries, including India.
Dr Mohan's is a scientist by profession and his research over the last decade revolved around undertaking 'patient - oriented' clinical research studies, predominantly in cardiometabolic diseases. He joined University of Warwick in January 2018 and is currently working with Prof Swaran Singh at the Centre for Mental Health and Wellbeing Research as a Senior Research Fellow / Programme Manager, leading an NIHR Global Health Research Group on Psychosis Outcomes: the Warwick- India-Canada {WIC} Network, focused on reducing the burden of psychotic disorders in India. Prior to this, he was working at the University of Dundee, Scotland where he was a British Heart Foundation research fellow and also completed his PhD in cardiovascular medicine. His doctoral research was around repurposing the diabetic drug, metformin in cardiovascular diseases, where he showed for the first time in a randomized controlled clinical trial that metformin can reduce left ventricular hypertrophy in high risk cardiovascular patients, who have non-diabetic hyperglycemia. He also have two MSc (one in Bioinformatics and one in Biotechnology). Dr Mohan has extensive experience in running and managing clinical trials, Big Data studies and multicentre observational studies funded by various large funding agencies, including EU FP-7. He is an experienced clinical researcher in cardiometabolic disorders and have worked in various academic institutions, in UK and India.
- 'Sood, Mamta, 'Chadda, Rakesh Kumar, 'Chawla, Nishtha, 'Sharma, Mona R., 'Patel, Rekha, 'Mohan, Mohapradeep, 'Iyer, Srividya, 'Padmavati, R., 'Thara, Rangaswamy, 'Singh, Swaran P., 2022. 'Understanding needs of stakeholders and outcomes desired from a home-based intervention program for ?difficult to treat? schizophrenia and related disorders : a qualitative study. Indian Journal of Psychiatry, 64 (1)
- Singh, Swaran P., Mohan, Mohapradeep, Giacco, Domenico, Singh, Swaran P., Mohan, Mohapradeep, Giacco, Domenico, 2021. Psychosocial interventions for people with a first episode psychosis : between tradition and innovation. Current Opinion in Psychiatry, 34 (5), pp. 460-466
- 'Singh, Swaran P., 'Mohan, Mohapradeep, 'Giacco, Domenico, 2021. 'Psychosocial interventions for people with a first episode psychosis : between tradition and innovation. Current Opinion in Psychiatry, 34 (5), pp. 460-466
- Mohan, Mohapradeep, Dihoum, Adel, Mordi, Ify R., Choy, Anna-Maria, Rena, Graham, Lang, Chim C., 2021. Left ventricular hypertrophy in diabetic cardiomyopathy : a target for intervention. Frontiers in Cardiovascular Medicine, 8
- Curran, Fraser M., Bhalraam, U., Mohan, Mohapradeep, Singh, Jagdeep S., Anker, Stefan D., Dickstein, Kenneth, Doney, Alexander S., Filippatos, Gerasimos, George, Jacob, Metra, Marco, Ng, Leong L., Palmer, Colin N., Samani, Nilesh J., Veldhuisen, Dirk J., Voors, Adriaan A., Lang, Chim C., Mordi, Ify R., 2021. Neutrophil?to?lymphocyte ratio and outcomes in patients with new?onset or worsening heart failure with reduced and preserved ejection fraction. ESC Heart Failure, 8 (4), pp. 3168-3179
- Dhandapani, Vijaya Raghavan, Ramachandran, Padmavati, Mohan, Greeshma, Chandrasekaran, Sangeetha, Paul, Vimala, Pattabiraman, Ramakrishnan, Mohan, Mohapradeep, Iyer, Srividya, Rangaswamy, Thara, Singh, Swaran P., 2021. Situational analysis of prevailing practices in the management of first?episode psychosis in Chennai, India. Early Intervention in Psychiatry, 15 (3), pp. 739-741
- Dhandapani, Vijaya Raghavan, Chandrasekaran, Sangeetha, Singh, Saurabh, Sood, Mamta, Chadda, Rakesh K, Shah, Jai, Iyer, Srividya, Meyer, Caroline, Mohan, Mohapradeep, Birchwood, Max, Madan, Jason, Currie, Graeme, Ramachandran, Padmavati, Rangaswamy, Thara, Singh, Swaran P., 2021. Community stakeholders' perspectives on youth mental health in India : problems, challenges and recommendations. Early Intervention in Psychiatry, 15 (3), pp. 716-722
- Mohan, Mohapradeep, Perry, Benjamin Ian, Saravanan, Ponnusamy, Singh, Swaran P., 2021. COVID-19 in people with schizophrenia : potential mechanisms linking schizophrenia to poor prognosis. Frontiers in Psychiatry, 12
- Singh, Swaran P., Mohan, Mohapradeep, Iyer, Srividya N., Meyer, Caroline, Currie, Graeme, Shah, Jai, Madan, Jason, Birchwood, M. J., Sood, Mamta, Ramachandran, Padmavati, Chadda, Rakesh K., Lilford, Richard J., Rangaswamy, Thara, Furtado, Vivek, 2021. The Warwick-India-Canada (WIC) global mental health group : rationale, design and protocol. BMJ Open, 11
- Cao, Thong H., Jones, Donald J. L., Voors, Adriaan A., Quinn, Paulene A., Sandhu, Jatinderpal K., Chan, Daniel C.S., Parry, Helen M., Mohan, Mohapradeep, Mordi, Ify R., Sama, Iziah E., Anker, Stefan D., Cleland, John G., Dickstein, Kenneth, Filippatos, Gerasimos, Hillege, Hans L., Metra, Marco, Ponikowski, Piotr, Samani, Nilesh J., Van Veldhuisen, Dirk J., Zannad, Faiez et al (Select to open full list), 2020. Plasma proteomic approach in patients with heart failure : insights into pathogenesis of disease progression and potential novel treatment targets. European Journal of Heart Failure, 22 (1), pp. 70-80
- Dhandapani, Vijaya Raghavan, Chandrasekaran, Sangeetha, Singh, Saurabh, Sood, Mamta, Chadda, Rakesh K, Shah, Jai, Iyer, Srividya, Meyer, Caroline, Mohan, Mohapradeep, Birchwood, Max, Madan, Jason, Currie, Graeme, Ramachandran, Padmavati, Rangaswamy, Thara, Singh, Swaran P., 2020. Community stakeholders' perspectives on youth mental health in India : problems, challenges and recommendations. Early Intervention in Psychiatry
- Singh, J. S. S., Mordi, I. R., Vickneson, K., Fathi, A., Donnan, P. T., Mohan, Mohapradeep, Choy, A. M. J., Gandy, S., George, J., Khan, F., Person, E. R., Houston, J. G., Struthers, A. D., Lang, C. C., 2020. Dapagliflozin versus placebo on left ventricular remodeling in patients with diabetes and heart failure : The REFORM trial. Diabetes Care, 43 (6), pp. 1356-1359
- Mordi, Ify R., Mohan, Mohapradeep, Lang, Chim C., 2020. Letter by Mordi et al Regarding Article, ?Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial?. Circulation, 141 (4), pp. e55-e56
- Mohan, Mohapradeep, Iskandar, Zaid, Mordi, Ify, Yeow, Casserene, Neaogoie, Alex, Rena, Graham, Chew, Samuel, Lang, Chim, 2019. Metformin and its potential for heart failure with preserved ejection fraction. Journal of Diabetes and Treatment, 4 (2)
- Mohan, Mohapradeep, Al-Talabany, Shaween, McKinnie, Angela, Mordi, Ify R., Singh, Jagdeep S. S., Gandy, Stephen J., Baig, Fatima, Hussain, Muhammad S., Bhalraam, U., Khan, Faisel, Choy, Anna-Maria, Matthew, Shona, Houston, John Graeme, Struthers, Allan D., George, Jacob, Lang, Chim C., 2019. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes : the MET-REMODEL trial. European Heart Journal, 40 (41), pp. 3409-3417
- Cao, Thong Huy, Jones, Donald J. L., Quinn, Paulene A., Chan, Daniel Chu Siong, Hafid, Narayan, Parry, Helen M., Mohan, Mohapradeep, Sandhu, Jatinderpal K., Anker, Stefan D., Cleland, John G., Dickstein, Kenneth, Filippatos, Gerasimos, Hillege, Hans L., Metra, Marco, Ponikowski, Piotr, Samani, Nilesh J., Van Veldhuisen, Dirk J., Zannad, Faiez, Zwinderman, Aeilko H., Voors, Adriaan A. et al (Select to open full list), 2018. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clinical Proteomics, 15
- Cameron, Amy R., Morrison, Vicky L., Levin, Daniel, Mohan, Mohapradeep, Forteath, Calum, Beall, Craig, McNeilly, Alison D., Balfour, David J. K., Savinko, Terhi, Wong, Aaron K. F., Viollet, Benoit, Sakamoto, Kei, Fagerholm, Susanna C., Foretz, Marc, Lang, Chim C., Rena, Graham, 2016. Anti-inflammatory effects of metformin irrespective of diabetes status. Circulation research, 119 (5), pp. 652-65
- Singh, Jagdeep S. S., Fathi, Amir, Vickneson, Keeran, Mordi, Ify, Mohan, Mohapradeep, Houston, J. Graeme, Pearson, Ewan R., Struthers, Allan D., Lang, Chim C., 2016. Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design. Cardiovascular Diabetology, 15
- Mohan, Mohapradeep, Hawkey, Sean, Baig, Fatima, Choy, Anna Maria, Lang, Chim C., 2015. Underutilization of IV nitrates in the treatment of acute heart failure. Cardiovascular Therapeutics, 33 (4), pp. 247-52
- Mohan, Mohapradeep, McSwiggan, Stephen, Baig, Fatima, Rutherford, Lynn, Lang, Chim C., 2015. Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study) : rationale and design of the MET-REMODEL study. Cardiovascular Therapeutics, 33 (1), pp. 1-8
- Elder, Douglas H., Mohan, Mohapradeep, Cochrane, Lynda, Charles, Helena, Lang, Chim C., 2015. Characterizing patients with chronic heart failure in community care after hospitalization : a potential role for ivabradine. Cardiovascular Therapeutics, 33 (3), pp. 104-108
- Zachariah, D., Brown, R., Kanagala, P., Bashir, A., Mohan, Mohapradeep, Callan, P., Rajendra, R., Clark, A. L., Squire, I., Gunning, M., Lang, C. C., Kalra, P. R., 2014. The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention. QJM : monthly journal of the Association of Physicians, 107 (3), pp. 185-192
- Singh, Jagdeep S. S., Mordi, Ify, Mohan, Mohapradeep, Gandy, Stephen J., Pearson, Ewan, Houston, John G., Struthers, Allan D., Lang, Chim C., 2018. Research into the effect of sodium-glucose linked transporter 2 inhibition on left ventricular remodeling in patients with heart failure and diabetes mellitus. American Diabetes Association, Florida, Published in Diabetes, pp. 256-OR
- Mohan, Mohapradeep, Al-Talabany, S., McKinnie, A., Mordi, I., Singh, J. S. S., Gandy, S, Khan, F., Choy, A. M., Houston, J. G., George, J., Struthers, A. D., Lang, C. C., 2018. Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM. European Society of Cardiology, Munich, Germany, Published in European Heart Journal
- Singh, Jagdeep, Mordi, Ify, Fathi, Amir, Vickneson, Keeran, T Donnan, P., Mohan, Mohapradeep, Choy, Anna Maria, G Gandy, S., R Pearson, E., Houston, John, D Struthers, A., Lang, Chim, 2018. Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus. European Society of Cardiology, Munich, suppl_1, Published in European Heart Journal
- Mohan, Mohapradeep, Al-Talabany, Shaween, Mckinnie, Angela M., Mordi, Ify, Singh, Jagdeep S., Gandy, Stephen J., Choy, Annamaria, Houston, John G., George, Jacob, Struthers, Allan D., Lang, Chim C., 2018. Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without Type 2 diabetes mellitus?The MET-REMODEL Trial. American Diabetes Association 2018, Florida, Published in Diabetes, pp. 167-OR
- Al-Talabany, S., Weir-McCall, Jonathan, Mohan, Mohapradeep, Singh, Jagdeep, Mordi, Ify, Gandy, S., Khan, Firoze, Choy, Anna Maria, Houston, John, Ewan, P., George, J., Struthers, A., Lang, Chim, 2018. MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients. European Society of cardiology, Munich, Published in European Heart Journal
- Al-Talabany, S., Weir-McCall, J., Mohan, Mohapradeep, Singh, J., Mordi, I., Gandy, S., Khan, F., Choy, A.M., Houston, G., Pearson, E., George, J., Struthers, A., Lang, C., 2018. Metformin and dapagliflozin effects on epicardial adipose tissue area in prediabetes and type 2 diabetes patients : MRI evaluation studies. World Congress of Cardiology & Cardiovascular Health 2018, Published in Global Heart
- Mordi, Ify, Levin, Daniel, Aracil, A., Mohan, Mohapradeep, Singh, Jagdeep, Struthers, A., Mccrimmon, Rory, Palmer, Colin, Doney, A., Lang, Chim, 2018. Insulin resistance, left ventricular hypertrophy and the impact of metformin use on cardiovascular outcomes in patients with calcific aortic stenosis : a genetic and population cohort study. European Society of cardiology, Munich, Published in European Heart Journal
- Mohan, Mohapradeep, 2017. Prevalence and clinical consequences of dysglycaemia in nondiabetic patients with chronic heart failure. European Society of Cardiology Acute Heart Failure Congress, Paris, France, 29 Apr ? 2 May 2017, Published in European Journal of Heart Failure
- Bhalraam, U., Mohan, Mohapradeep, Lang, Chim, 2017. Prognostic role of neutorphil to lymphocyte ratio in predicting outcomes in patients with chronic heart failure. Amerian College of Cardiology, Washington DC, Published in Journal of the American College of Cardiology
- Mohan, Mohapradeep, 2016. Anti-inflammatory effects of metformin in diabetic patients and non-diabetic heart failure patients. Acute Heart Failure Congress, European Society of Cardiology, Florence, Italy, Published in European Journal of Heart Failure, pp. 8-521
- Mohan, Mohapradeep, Levin, Daniel, Choy, Anna-Maria, Struthers, Allan, Lang, Chim, 2015. Clinical utility of combined platelet count and neutrophil-to-lymphocyte ratio, a simple blood test, in predicting outcome in patients with chronic heart failure. British Cardiovascular Society, Manchester, Published in Heart, pp. A23.2-A24
- Baig, Fatima, Lang, Chim, Mohan, Mohapradeep, Choy, Anna Maria, Chowdhury, Anika, 2015. Prolonged PR and QRS intervals predict outcome in patients With chronic heart failure. Asian Pacific Society of Cardiology, Abu Dhabi, Published in Global Heart
- Hawkey, Sean, Levin, Daniel, Mohan, Mohapradeep, Baig, Fatima, Iskandar, Muhammad, Rutherford, Lynn, Lang, Chim, Choy, Anna, 2015. Heart rate is not related to survival in patients with heart failure and atrial fibrillation. British Cardiovascular Society, Manchester, Published in Heart, pp. A15.2-A16
- Mohan, Mohapradeep, 2015. Prognostic role of combined platelet count and neutrophil-to-lymphocyte ratio in predicting outcome in patients with chronic heart failure. European Society of Cardiology Acute Heart Failure Congress, Spain, Published in European Journal of Heart Failure
- Lang, Chim C., Mohan, Mohapradeep, Levin, Daniel, Choy, Anna Maria, Struthers, Allan D., 2015. Prognostic role of combined platelet count and neutrophil-to-lymphocyte ratio in predicting outcome in patients with chronic heart failure. American College of Cardiology, California, Published in Journal of the American College of Cardiology
- Lang, Chim C., Levin, Daniel, Mohan, Mohapradeep, Parry, Helen, Elder, Douglas, Struthers, Allan D., Choy, Anna Maria, 2015. Effect of glycaemic control on outcome in patients with type 2 diabetes mellitus and chronic heart failure. American College of Cardiology, San Diego, California, Published in Journal of the American College of Cardiology
- Mohan, Mohapradeep, Lang, Chim, 2015. Prognostic role of neutrophil to lymphocyte ratio in predicting outcome in patients With chronic heart failure. Asian Pacific Society of Cardiology, Abu Dhabi, Published in Global Heart
- Mohan, Mohapradeep, Deshmukh, Harshal, Baig, Fatima, Lynn, Rutherford, Elder, Douglas, Choy, nna Maria, Lang, Chim, 2014. Insulin resistance is associated with all-cause mortality and accelerates the risk of progression to diabetes in non diabetic heart failure patients. American College of Cardiology, Washington DC, Published in Journal of the American College of Cardiology
- Mohan, Mohapradeep, Deshmukh, Harshal, Baig, Fatima, Hawkey, Sean, Rutherford, Lynn, Struthers, Allan, Choy, Anna Maria, Lang, Chim, 2014. Neutrophil to lymphocyte ratio predicts all-cause mortality in patients with chronic heart failure. American Heart Association Conference, Chicago, Published in Circulation
- Mohan, Mohapradeep, 2014. Prevalence of pre-diabetes among non-diabetic heart failure patients. European Society of Cardiology Acute Heart Failure Congress, Portugal, 25-28 May 2013, Published in European Journal of Heart Failure, pp. S73-S325
- Mohan, Mohapradeep, Deshmukh, Harshal, Maria Choy, Anna, Lang, Chim, 2014. Insulin resistance is associated with all-cause mortality and accelerates the risk of progression to diabetes in non-diabetic heart failure patients. British Cardiovascular Society, Manchester, Published in Heart, pp. A34.2-A34
- Mohan, Mohapradeep, 2019. Metformin reduces left ventricular mass in nondiabetic patients with CAD. Cardiovascular Business, TriMed Media Group, Inc
- Mohan, Mohapradeep, 2019. Commonly used diabetic drug - Metformin, beneficial for non-diabetic patients. ETHealthworld.com from The Economic Times, Bennett Coleman & Co. Ltd
- Mohan, Mohapradeep, 2018. 'Best of the Best' Research, British Cardiovascular Society (2018). University of Dundee
- Mohan, Mohapradeep, 2017. Impressing the British - STEM for Britain 2017. The New Indian Express, Express Publications (Madurai) Ltd
- Mohan, Mohapradeep, 2017. Young scientists to present research at House of Commons. University of Dundee
- Mohan, Mohapradeep, 2016. Award for 'outstanding' research. University of Dundee
Title | Funder | Award start | Award end |
---|---|---|---|
NIHR WIC Extension | National Institute for Health Research (DoH) | 01 Jul 2020 | 31 Jan 2022 |